LAUSR

BACKGROUND The introduction of carotid stenting (CAS) has led to numerous comparative trials with carotid endarterectomy (CEA). OBJECTIVE To review real-world volumes, outcomes and complications following CEA versus CAS over an extended period to identify durable changes in practice. METHODS Data were extracted from the National Inpatient Sample. Trends were assessed by annual percent change (APC) and adjusted risk ratios (aRR)s were calculated across the last 5 years of the study period. RESULTS During 1997-2015, 199,330 symptomatic and 1,995,637 asymptomatic patients underwent carotid revascularization. In symptomatic patients, CEA declined (1997-2004; APC -7.68%, p<0.001) and CAS rose (1997-2008; APC 15.48%, p<0.001) during the first decade, subsequently becoming more muted. In asymptomatic patients, CEA decreased whereas CAS initially increased (1997-2006; APC 20.27%, p<0.001) and then decreased (2007-2015; APC -4.52%, p<0.001). Routine discharge after symptomatic revascularization declined in CEA after 2003 and in CAS after 2006 (APC -1.72% and -3.11% respectively, p<0.001 for both), corresponding to increasing patient comorbidity; similar trends were seen in asymptomatic patients. Death decreased after CEA (symptomatic and asymptomatic; APC -4.85% and -3.53% respectively, p<0.001 for both) and CAS (asymptomatic only, APC -2.53%, p=0.04). CAS remained associated with higher aRR for death, venous thromboembolism and seizures in all patients, and stroke and non-routine discharge in symptomatic patients, during the last 5 years of the study period. CONCLUSIONS Mortality has improved but routine discharge has decreased following both CEA and CAS, congruent with increasing patient comorbidity. Trends in volumes, outcomes and complication rates continue to favor CEA in real-world practice.